ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.730,57
0,86%
S&P 500
5.354,03
1,18%
Dow Jones
38.807,33
0,25%
Euro vs US Dollar
1,0878
0,04%
Bitcoin
70.999,89
-0,11%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Ardelyx Inc (ARDX)

  7. Ardelyx Inc (ARDX) News

ARDX

Ardelyx (ARDX)

Ardelyx Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ARDX
DatumZeitQuelleÜberschriftSymbolFirma
06/06/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
06/06/202400h09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARDXArdelyx Inc
04/06/202414h57Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARDXArdelyx Inc
30/05/202422h02GlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
23/05/202422h58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARDXArdelyx Inc
23/05/202422h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
23/05/202422h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
23/05/202422h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
23/05/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
23/05/202422h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
23/05/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
22/05/202414h02GlobeNewswire Inc.Ardelyx to Participate at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:ARDXArdelyx Inc
21/05/202414h02GlobeNewswire Inc.Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in AdultsNASDAQ:ARDXArdelyx Inc
16/05/202414h01GlobeNewswire Inc.Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)NASDAQ:ARDXArdelyx Inc
14/05/202422h02GlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
09/05/202422h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
07/05/202422h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
07/05/202414h01GlobeNewswire Inc.Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week ConferenceNASDAQ:ARDXArdelyx Inc
02/05/202422h02GlobeNewswire Inc.Ardelyx Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARDXArdelyx Inc
01/05/202414h00GlobeNewswire Inc.Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical MeetingsNASDAQ:ARDXArdelyx Inc
18/04/202414h00GlobeNewswire Inc.Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024NASDAQ:ARDXArdelyx Inc
28/03/202421h05GlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
25/03/202413h00GlobeNewswire Inc.Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and StrategyNASDAQ:ARDXArdelyx Inc
12/03/202421h35GlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
05/03/202422h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARDXArdelyx Inc
29/02/202400h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
27/02/202414h00GlobeNewswire Inc.Ardelyx to Participate at the Cowen 44th Annual Health Care ConferenceNASDAQ:ARDXArdelyx Inc
23/02/202400h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
22/02/202423h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
22/02/202422h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
 Showing the most relevant articles for your search:NASDAQ:ARDX

Kürzlich von Ihnen besucht

ASX
CG1
Carbonxt
NASDAQ
MPLAVX
Buffer 20 Mps 132
BFNX
WAXETH
EU
SMAL
Departement Seine et Mar...
EU
DBRBB
Departement Bouches du R...
BIT
P1TSL0
NLBNPIT1TSL0 20240620 16...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten